159 related articles for article (PubMed ID: 1871136)
21. Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates.
Chen CJ; Banerjea AC; Harmison GG; Haglund K; Schubert M
Nucleic Acids Res; 1992 Sep; 20(17):4581-9. PubMed ID: 1408760
[TBL] [Abstract][Full Text] [Related]
22. Inhibitors of human immunodeficiency virus integrase.
Fesen MR; Kohn KW; Leteurtre F; Pommier Y
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2399-403. PubMed ID: 8460151
[TBL] [Abstract][Full Text] [Related]
23. Expression of functional HIV-1 integrase in the yeast Saccharomyces cerevisiae leads to the emergence of a lethal phenotype: potential use for inhibitor screening.
Caumont AB; Jamieson GA; Pichuantes S; Nguyen AT; Litvak S; Dupont C
Curr Genet; 1996 May; 29(6):503-10. PubMed ID: 8662188
[TBL] [Abstract][Full Text] [Related]
24. Analysis of human immunodeficiency virus type 1 integrase mutants.
Ansari-Lari MA; Donehower LA; Gibbs RA
Virology; 1995 Nov; 213(2):680. PubMed ID: 7491794
[No Abstract] [Full Text] [Related]
25. Comparison of in vivo activities of 5'-connected and 3'-connected cis-acting ribozymes: selection of intracellularly active ribozymes using the gene for dihydrofolate reductase (DHFR) as a selective marker in Escherichia coli.
Hamada M; Fujita S; Kise H; Jigami Y; Taira K
J Biochem; 1998 Apr; 123(4):684-92. PubMed ID: 9538262
[TBL] [Abstract][Full Text] [Related]
26. Activities of HIV-RNA targeted ribozymes transcribed from a 'shot-gun' type ribozyme-trimming plasmid.
Ohkawa J; Yuyama N; Taira K
Nucleic Acids Symp Ser; 1992; (27):15-6. PubMed ID: 1289797
[TBL] [Abstract][Full Text] [Related]
27. ILG1 : a new integrase-like gene that is a marker of bacterial contamination by the laboratory Escherichia coli strain TOP10F'.
Tian W; Chua K; Strober W; Chu CC
Mol Med; 2002 Jul; 8(7):405-16. PubMed ID: 12393938
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of human immunodeficiency virus type-1 integrase by curcumin.
Mazumder A; Raghavan K; Weinstein J; Kohn KW; Pommier Y
Biochem Pharmacol; 1995 Apr; 49(8):1165-70. PubMed ID: 7748198
[TBL] [Abstract][Full Text] [Related]
29. Hammerhead ribozyme-mediated cleavage of the long terminal repeat RNA of human immunodeficiency virus type 1.
Heidenreich O; Eckstein F
J Biol Chem; 1992 Jan; 267(3):1904-9. PubMed ID: 1730726
[TBL] [Abstract][Full Text] [Related]
30. Analysis of human immunodeficiency virus type 1 integrase mutants.
Ansari-Lari MA; Donehower LA; Gibbs RA
Virology; 1995 Aug; 211(1):332-5. PubMed ID: 7544046
[TBL] [Abstract][Full Text] [Related]
31. A soluble active mutant of HIV-1 integrase: involvement of both the core and carboxyl-terminal domains in multimerization.
Jenkins TM; Engelman A; Ghirlando R; Craigie R
J Biol Chem; 1996 Mar; 271(13):7712-8. PubMed ID: 8631811
[TBL] [Abstract][Full Text] [Related]
32. Retroviral integrases and their cousins.
Rice P; Craigie R; Davies DR
Curr Opin Struct Biol; 1996 Feb; 6(1):76-83. PubMed ID: 8696976
[TBL] [Abstract][Full Text] [Related]
33. In vitro biochemical activities associated with recombinant HIV-1 integrase.
Pemberton IK; Singh OM
Biochem Soc Trans; 1993 Feb; 21(1):51S. PubMed ID: 8449335
[No Abstract] [Full Text] [Related]
34. Site-specific cleavage of natural mRNA sequences by newly designed hairpin catalytic RNAs.
Kikuchi Y; Sasaki N
Nucleic Acids Res; 1991 Dec; 19(24):6751-5. PubMed ID: 1762907
[TBL] [Abstract][Full Text] [Related]
35. Structural implications of spectroscopic characterization of a putative zinc finger peptide from HIV-1 integrase.
Burke CJ; Sanyal G; Bruner MW; Ryan JA; LaFemina RL; Robbins HL; Zeft AS; Middaugh CR; Cordingley MG
J Biol Chem; 1992 May; 267(14):9639-44. PubMed ID: 1577801
[TBL] [Abstract][Full Text] [Related]
36. Specific gene suppression by engineered ribozymes in monkey cells.
Cameron FH; Jennings PA
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9139-43. PubMed ID: 2556702
[TBL] [Abstract][Full Text] [Related]
37. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.
Mazumder A; Wang S; Neamati N; Nicklaus M; Sunder S; Chen J; Milne GW; Rice WG; Burke TR; Pommier Y
J Med Chem; 1996 Jun; 39(13):2472-81. PubMed ID: 8691444
[TBL] [Abstract][Full Text] [Related]
38. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
[TBL] [Abstract][Full Text] [Related]
39. A novel assay for the DNA strand-transfer reaction of HIV-1 integrase.
Hazuda DJ; Hastings JC; Wolfe AL; Emini EA
Nucleic Acids Res; 1994 Mar; 22(6):1121-2. PubMed ID: 8152918
[No Abstract] [Full Text] [Related]
40. Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.
Sun LQ; Wang L; Gerlach WL; Symonds G
Nucleic Acids Res; 1995 Aug; 23(15):2909-13. PubMed ID: 7544887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
